ATE149834T1 - Pyridylguanidine verbindungen zur behandlung von erektionsstörungen - Google Patents

Pyridylguanidine verbindungen zur behandlung von erektionsstörungen

Info

Publication number
ATE149834T1
ATE149834T1 AT92925443T AT92925443T ATE149834T1 AT E149834 T1 ATE149834 T1 AT E149834T1 AT 92925443 T AT92925443 T AT 92925443T AT 92925443 T AT92925443 T AT 92925443T AT E149834 T1 ATE149834 T1 AT E149834T1
Authority
AT
Austria
Prior art keywords
erective
disorder
treatment
pyridylguanidine
compounds
Prior art date
Application number
AT92925443T
Other languages
English (en)
Inventor
Allen E Buhl
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE149834T1 publication Critical patent/ATE149834T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92925443T 1991-12-23 1992-12-02 Pyridylguanidine verbindungen zur behandlung von erektionsstörungen ATE149834T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81670091A 1991-12-23 1991-12-23

Publications (1)

Publication Number Publication Date
ATE149834T1 true ATE149834T1 (de) 1997-03-15

Family

ID=25221384

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92925443T ATE149834T1 (de) 1991-12-23 1992-12-02 Pyridylguanidine verbindungen zur behandlung von erektionsstörungen

Country Status (12)

Country Link
US (1) US5488059A (de)
EP (1) EP0618798B1 (de)
JP (1) JPH07506333A (de)
KR (1) KR940703666A (de)
AT (1) ATE149834T1 (de)
AU (1) AU661747B2 (de)
CA (1) CA2123312A1 (de)
DE (1) DE69218246T2 (de)
DK (1) DK0618798T3 (de)
ES (1) ES2099293T3 (de)
GR (1) GR3023448T3 (de)
WO (1) WO1993012788A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6007843A (en) 1995-09-29 1999-12-28 Lam Pharmaceuticals Corp. Sustained release delivery system
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
WO2000067754A1 (en) 1999-05-12 2000-11-16 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6436944B1 (en) * 1999-09-30 2002-08-20 Pfizer Inc. Combination effective for the treatment of impotence
KR20010076961A (ko) * 2000-01-29 2001-08-17 김제종 성기능장애 예방 및 치료용 약제
US9296697B2 (en) 2005-08-24 2016-03-29 Abbott Laboratories Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment

Also Published As

Publication number Publication date
AU3149793A (en) 1993-07-28
DK0618798T3 (da) 1997-09-22
EP0618798B1 (de) 1997-03-12
WO1993012788A1 (en) 1993-07-08
CA2123312A1 (en) 1993-07-08
GR3023448T3 (en) 1997-08-29
KR940703666A (ko) 1994-12-12
AU661747B2 (en) 1995-08-03
ES2099293T3 (es) 1997-05-16
DE69218246T2 (de) 1997-07-17
JPH07506333A (ja) 1995-07-13
US5488059A (en) 1996-01-30
DE69218246D1 (de) 1997-04-17
EP0618798A1 (de) 1994-10-12

Similar Documents

Publication Publication Date Title
DK0660705T3 (da) Avanceret lægemiddelafgivelsessystem og fremgangsmåde til behandling af psykiatriske, neurologiske og andre lidelser med ca
DK0480934T3 (da) Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
SE8803087L (sv) Ett nytt saett foer behandling av erektil dysfunktion
EA200001044A3 (ru) Соединения для лечения женской сексуальной дисфункции
CO4290359A1 (es) Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasa
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DK0415613T3 (da) Anvendelse af sertralin til behandling af præmatur ejakulation
MY106528A (en) Method of treating impotence.
ATE149834T1 (de) Pyridylguanidine verbindungen zur behandlung von erektionsstörungen
EA200200324A1 (ru) Способы применения селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции
ES2166001T3 (es) Utilizacion de compuestos antimineralcorticoides contra el sindrome de abstinencia de narcoticos.
DE69210654D1 (de) Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
SE9202208D0 (sv) Vaevnadsfoerstaerkning
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
AP9100336A0 (en) Method for the treatment ofnematodes in soil using furfural.
RU2003118131A (ru) Способ лечения ран
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
ATE149840T1 (de) Behandlung von leberkrebs
ATE183095T1 (de) Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
RU96122371A (ru) Способ лечения эндогенных и послеоперационных увеитов
RU96122672A (ru) Эхинамакс. способ лечения астенических состояний при физиогенных дезадаптациях

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee